Luminex Corp
Change company Symbol lookup
Select an option...
LMNX Luminex Corp
NWS News Corp
TUES Tuesday Morning Corp
LXXGF Lexagene Holdings Inc
BKE Buckle Inc
CRMT America's CAR-MART Inc
DE Deere & Co
JKS JinkoSolar Holding Co Ltd
TLGT Teligent Inc (NEW JERSEY)
ALK Alaska Air Group Inc
Go

Health Care : Life Sciences Tools & Services | Small Cap Blend
Company profile

Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company's products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments. The Company has a range of instruments using its xMAP technology, which includes its LUMINEX 100/200 systems offer 100-plex testing; the Company's FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry. By using its xMAP technology, the end users are able to generate multiple simultaneous results per sample. The Company primarily serves the diagnostics, pharmaceutical and life sciences industries by marketing products, including its testing equipment and assays, to a range of testing laboratories.

Closing Price
$31.49
Day's Change
0.19 (0.61%)
Bid
--
Ask
--
B/A Size
--
Day's High
31.68
Day's Low
30.95
Volume
(Light)
Volume:
367,323

10-day average volume:
1,200,684
367,323

Company Profile

Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company's products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments. The Company has a range of instruments using its xMAP technology, which includes its LUMINEX 100/200 systems offer 100-plex testing; the Company's FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry. By using its xMAP technology, the end users are able to generate multiple simultaneous results per sample. The Company primarily serves the diagnostics, pharmaceutical and life sciences industries by marketing products, including its testing equipment and assays, to a range of testing laboratories.

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
4.21x
Price/Book (MRQ)
3.04x
Price/Cash Flow (TTM)
88.30x
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend

Short Interest

April 2020
Current Month
1.9M
Previous Month
1.8M
Percent of Float
4.40%
Days to Cover
2.9725 Days

Share Information

LMNX is in a share class of common stock
Float
43.3M
Shares Outstanding
45.8M
Institutions Holding Shares
235
84.33%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in thousands.

Company Officers

  • George Walter LoewenbaumChmn.
  • Nachum ShamirPres.
  • Harriss T. CurrieCFO
  • Richard W. RewSr.VP
  • Todd C. BennettSr.VP

Address

Insider Trading

During the most recent quarter, 291K shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2020. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.